GLP-1 Innovation Landscape 2026: Industry Insights

GLP-1 drugs are reshaping more than healthcare. They are also changing how consumers eat, shop, and think about food and drinks.

GLP-1 Innovation Landscape 2026: Industry Insights examines how rising GLP-1 adoption is creating new opportunities across retail, food, beverages, brands, and weight management.

The report explores the consumer behaviors driving this shift. It also identifies how retailers and brands are responding with new products, formulations, portion sizes, and positioning.

You can use this analysis to size the GLP-1-driven consumer opportunity, identify emerging product needs, and develop innovation strategies that align with changing eating behaviors.

GLP-1 Market Growth and Consumer Impact

GLP-1 use is expanding beyond diabetes treatment and into mainstream weight management.

Global GLP-1 drug sales are forecast to increase from $76 billion in 2025 to $161.9 billion in 2031.

As adoption grows, the impact may extend further across the consumer landscape.

GLP-1 users tend to eat less and feel full faster. They may also become more sensitive to richer foods.

This creates demand for smaller portions and nutrient-dense products. Therefore, food and beverage companies may need to rethink how products deliver nutrition, convenience, and value.

GLP-1 Consumer Trends: What Are Users Looking for?

Understanding changing eating behavior is critical for product innovation.

The report examines the consumer drivers behind GLP-1-related food and beverage demand. It explores what consumers may want from products designed around reduced food intake and greater satiety.

Key areas include:

• Smaller and portion-controlled formats
• Higher-protein products
• Higher-fiber formulations
• Nutrient-dense foods
• Balanced nutrient and vitamin content
• Lower-calorie options
• Products designed around changing eating patterns

In addition, side effects such as nausea, constipation, and diarrhea may create opportunities for products that support tolerability.

Higher-fiber ingredients are one area highlighted by the analysis.

GLP-1 Friendly Food and Beverage Innovation

The growth of GLP-1 use is creating a new innovation opportunity for food and beverage companies.

Retailers are moving quickly with products positioned around the needs of GLP-1 users. New ranges can include portion-controlled, high-protein, high-fiber, lower-calorie, and micronutrient-focused products.

Brands are generally taking a more cautious approach.

Rather than explicitly targeting GLP-1 users, many manufacturers are adapting existing products around attributes that may appeal to them.

These include protein, nutrient density, and smaller portions.

This creates a potential innovation pathway for brands that want to respond to the trend without relying entirely on explicit GLP-1 positioning.

GLP-1 Retail Innovation: What Leading Retailers Are Doing

Retailers are emerging as important innovators in the GLP-1 food market.

The report examines current retail innovation and the strategies behind new product launches.

It highlights UK retailer activity around “GLP-1 friendly” ranges. These launches provide an early template for how the market may develop.

You can use these examples to assess:

• Which product attributes retailers are prioritizing
• How portion control is being incorporated
• How protein and fiber are being communicated
• Which on-pack messages may attract consumers
• How retailers are positioning products for GLP-1 users
• Where potential whitespace remains

The analysis also explores the playbook behind “Jab-uary” launches and what these initiatives may signal for brands.

GLP-1 Brand Innovation: Identify Product Whitespace

The GLP-1 opportunity is not limited to dedicated product ranges.

Brands can also adapt existing products to meet changing consumer needs.

The report examines how manufacturers are responding through product formulation and innovation. It also explores the importance of “real food” cues, nutrient density, and portion control.

You can use these insights to identify potential whitespace across food and beverage categories.

Moreover, the analysis can help you distinguish between products that simply reference the trend and products that may deliver meaningful benefits to consumers.

GLP-1 Food and Drink Formulation Trends

GLP-1 users may have different requirements from traditional weight-management consumers.

The report explores the formulation requirements associated with GLP-1-driven demand. It considers how protein, fiber, micronutrients, portion size, and calorie density can influence product development.

This can help you assess whether existing products are aligned with emerging consumer needs.

It may also inspire new concepts across ready meals, snacks, beverages, and other food formats.

Scope

Retailers are moving faster in this space than brands with explicit GLP‑1 ranges: UK retailers have launched “GLP‑1 friendly” lines (portion-controlled, high protein/fiber, lower calorie, added micronutrients), setting a template for the market.

Brands are mostly taking a cautious approach: many manufacturers are quietly aligning with the needs of GLP-1 users (protein, nutrient density, smaller portions) rather than overtly targeting them.

Who Should Buy This GLP-1 Innovation Report?

This report is particularly relevant for:

• Food and beverage manufacturers
• Consumer packaged goods companies
• Retailers and supermarkets
• Food and beverage brand owners
• Product development teams
• Innovation leaders
• Category managers
• Marketing and consumer insight teams
• Corporate strategy teams
• Business development teams
• Investment and market intelligence professionals

If you are responsible for product innovation, category strategy, consumer insights, or growth, this report can help you assess how GLP-1 adoption may reshape your market.

What This GLP-1 Innovation Report Covers

The analysis includes:

• GLP-1 agonists explained
• UK and US GLP-1 user numbers
• Global GLP-1 market forecasts
• Wegovy pill forecasts
• Social media analytics
• “Weight management” product sales forecasts
• Consumer drivers
• Retail innovation
• Brand innovation
• GLP-1 innovation
• Innovation takeaways

Key Highlights

GLP‑1 adoption is accelerating and becoming a major demand driver: Use is rising quickly, with the global market projected to grow from $76 billion (2025) to $161.9 billion (2031). GLP-1 pills will expand access, but injectables remain the main growth engine.

Food needs are shifting because GLP‑1 changes eating behavior: Users eat less, feel full faster, and can be more sensitive to rich foods-creating demand for smaller, nutrient-dense portions that still deliver nutrition. The side effects of GLP-1 drug use (nausea/constipation/diarrhea) open up space for tolerability-supporting products, particularly those with higher-fiber ingredients.

• GLP-1 drugs (e.g., Ozempic, Wegovy) are expanding into mainstream weight management.
• They increase satiety and reduce food intake for rapid weight loss.
• Users eat less, feel full faster, and are sensitive to rich foods.
• Eating habits are shifting toward smaller, portion-controlled, and lower-calorie servings.
• Diet demands require nutrient-dense foods with high protein, fiber, and vitamins.
• Side effects like nausea, constipation, and diarrhea drive demand for tolerability-supporting, high-fiber products.
• Retailers are moving fastest by launching explicit “GLP-1 friendly” ready-meal lines.
• UK retailers have already set the market template with these targeted lines.
• Brands are taking a cautious approach by quietly reevaluating existing formulations.
• Manufacturers favor aligning with user needs over overt marketing.

Reasons to Buy

• Understand how big the GLP-1-driven opportunity is, why it matters, and how fast it is scaling. Get a clear view of adoption and revenue momentum to help size the commercial opportunity, inspire innovation ideas, and prioritize markets.
• Discover who is most interested in GLP-1 formulated food and drinks, what their formulation requirements are, and how this leads to concrete innovation opportunities.
• Deep dive into what retailers are doing right now and why it matters—the playbook behind “Jab-uary” launches, how to present key on-pack messages to convert interest into sales, and what this signals for brands.
• Understand what winning products need to deliver, where the whitespace is, why “real food” cues matter, and how to use portion control as part of final product delivery.

How Companies Can Use This GLP-1 Innovation Report

• This report is designed for practical innovation and commercial decisions.
• Food manufacturers can use it to identify formulation opportunities and assess how existing portfolios may need to evolve.
• Food and beverage brands can explore product attributes that may resonate with GLP-1 users without relying solely on explicit GLP-1 positioning.
• Retailers can benchmark emerging GLP-1-friendly ranges and identify opportunities across product categories.
• Product development teams can use the analysis to generate concepts around protein, fiber, nutrient density, portion control, and convenience.
• Marketing teams can assess consumer drivers and explore potential on-pack messaging.
• Innovation and strategy teams can use the market outlook to size the opportunity, prioritize markets, and identify emerging whitespace.

GLP-1 Innovation Report Value Proposition: Turn Consumer Change Into Product Opportunity

This report goes beyond explaining GLP-1 drugs. It shows what increasing GLP-1 adoption may mean for consumer behavior, retail strategy, food formulation, and brand innovation.

You can use the analysis to:

• Size the GLP-1-driven consumer opportunity
• Understand changing eating behaviors
• Identify high-potential product attributes
• Discover formulation opportunities
• Track retail innovation
• Benchmark emerging GLP-1-friendly ranges
• Identify product and category whitespace
• Develop new food and beverage concepts
• Refine product positioning and messaging
• Prioritize innovation opportunities
• Understand where brands may need to adapt

As a result, the report can help you connect a major health trend with practical consumer and commercial opportunities.

Act Now on the GLP-1 Consumer Opportunity

GLP-1 adoption is creating a new consumer landscape.

Retailers are already experimenting with dedicated product ranges. Meanwhile, brands are adapting formulations and product attributes more cautiously.

The opportunity is therefore moving beyond a pharmaceutical trend.

If you are evaluating how GLP-1 adoption could affect food, beverages, retail, or consumer behavior, this report can help you understand the opportunity, identify emerging innovation patterns, and decide where to focus next.